About
Terminalia chebula fruit extract is derived from the dried fruits of Terminalia chebula Retz. (family Combretaceae), a large deciduous tree native to South and Southeast Asia long revered in Ayurvedic, Tibetan, Siddha, and Unani medicine. It is used in food and nutraceutical applications primarily as an antioxidant, anti-inflammatory, and digestive aid, and is a key component of the classic Ayurvedic polyherbal formula Triphala.
Safety summary
Preclinical toxicology studies, including mutagenicity, cytotoxicity, hemolytic, and animal studies, have found no significant toxic effects at typical doses, supporting a broad safety margin. However, formal ADI values have not been established by any major regulatory authority (FDA, EFSA, FSSAI), and gaps remain in understanding the complete pharmacokinetics and long-term safety profiles of its extracts. Pregnant and lactating women are generally advised to consult a physician before use given the lack of controlled clinical safety data in these populations.
Regulatory landscape
| Jurisdiction | Status | Note |
|---|---|---|
| FSSAI (Food Safety and Standards Authority of India) (India) | Approved | Terminalia chebula (haritaki/harad) is a long-standing ingredient in Ayurvedic traditional medicine and food (e.g., as part of Triphala). FSSAI recognises Ayurvedic herbs in food products under its regulatory framework; no specific stand-alone maximum use level or ADI has been formally published for the isolated extract in general foods as of the latest available status list.source |
| FDA (Food and Drug Administration) (United States) | Approved | Terminalia chebula fruit extract is not listed in the FDA Substances Added to Food (EAFUS) inventory as a direct food additive with a specific regulation, and no GRAS notice has been publicly confirmed for this extract as a conventional food ingredient. It is commercially used as a dietary supplement ingredient under DSHEA; manufacturers are responsible for ensuring safety before marketing. Not explicitly banned or restricted.source |
Who should approach with care
Research citations
- 1PubMed. Mutagenicity and oral toxicity studies of Terminalia chebula. pubmed.ncbi.nlm.nih.gov
- 2PubMed. Safety assessment of methanolic extract of Terminalia chebula fruit, Terminalia arjuna bark and its bioactive constituent 7-methyl gallic acid: In vitro and in vivo studies. pubmed.ncbi.nlm.nih.gov
- 3PubMed. Comprehensive Review on Fruit of Terminalia chebula: Traditional Uses, Phytochemistry, Pharmacology, Toxicity, and Pharmacokinetics, 2024. pubmed.ncbi.nlm.nih.gov
- 4PubMed. A comprehensive review on the diverse pharmacological perspectives of Terminalia chebula Retz, 2022. pubmed.ncbi.nlm.nih.gov
- 5PubMed. The development of Terminalia chebula Retz. (Combretaceae) in clinical research, 2013. pmc.ncbi.nlm.nih.gov
